WO2023021480 - METHOD OF TREATING PARKINSON'S DISEASE
National phase entry:
Publication Number
WO/2023/021480
Publication Date
23.02.2023
International Application No.
PCT/IB2022/057814
International Filing Date
19.08.2022
Title **
[English]
METHOD OF TREATING PARKINSON'S DISEASE
[French]
PROCÉDÉ DE TRAITEMENT DE LA MALADIE DE PARKINSON
Applicants **
CLEXIO BIOSCIENCES LTD.
Inventors
MIMROD, Dorit
BERKOVICH, Elijahu
IZGELOV, Dvora
Priority Data
63/234,801
19.08.2021
US
63/315,183
01.03.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2459 | |
| EPO | Filing, Examination, Granting | 14285 | |
| Japan | Filing, Examination, Granting | 2524 | |
| South Korea | Filing, Examination, Granting | 2851 | |
| USA | Filing, Examination, Granting | 6140 |
Total:
28,259
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The disclosure is directed to methods of treating Parkinson's disease comprising administration of a capsule comprising an anti-parkinsonian medication and where the capsule's length is at least about 29mm and the capsule's width at least about 9.5mm.[French]
L'invention concerne des procédés de traitement de la maladie de Parkinson comprenant l'administration d'une capsule comprenant un médicament anti-parkinsonien, la longueur de la capsule étant d'au moins environ 29 mm et la largeur de la capsule étant d'au moins environ 9,5 mm.